Draxis Pharma, the contract manufacturing division of Draxis Health Inc., has appointed Bruce DeChambre as vice president commercial and business development. Mr. DeChambre’s responsibilities include identifying prospective customers and developing new business opportunities within the “blue chip” pharmaceutical sector while continuing to service to the company’s client base. He has more than  25 years of progressive pharmaceutical sales, marketing and business development experience with U.S.-based and international companies, including senior management responsibilities in the contract manufacturing sector.

Prior to joining DRAXIS Pharma, Mr. DeChambre was a pharmaceutical industry consultant to investment firms and healthcare advertising agencies. Previously, he was vice president sales and marketing at SAB-Pharma, the U.S. marketing arm of Sabex Inc., which was recently acquired by Novartis. He also
served as vice president bbusiness development for Cardinal Health’s Sterile Technology Group. In addition, Mr. DeChambre has served in senior sales and marketing management positions at Abraxis Pharmaceutical (formerly American Pharmaceutical Partners, Inc.), Fujisawa USA, Inc. and Baxter Healthcare.

Mr. John Durham, president of Draxis Pharma, stated, “We are pleased and excited to have Bruce join our management team. He brings a wealth of business development experience plus a broad network of senior level contacts in the pharmaceutical and biotechnology industries. His expertise in the sterile products area of the contract manufacturing sector is particularly relevant, given our strength and focus in the production of sterile injectables, ointments and creams as well as our expanding capabilities in sterile lyophilization.”